— Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected.
— Revenue increased 5% to $39.7 billion vs. $39.43 billion expected.
— GAAP EPS attributable to the company decreased to $0.75 from $0.93 in the second quarter of 2019.
— For FY20, Cardinal Health lifted non-GAAP EPS attributable to the company outlook to a range of $5.20 to $5.40 from the previous range of $4.85 to $5.10.
— Pharmaceutical segment revenue increased 6% year-over-year to $35.7 billion.
— Medical segment revenue was flat with prior-year-quarter at $4 billion.
— CAH stock rose about 6% in the pre-market trading session.
Most Popular
Key metrics from KB Home’s (KBH) Q4 2025 earnings results
KB Home (NYSE: KBH) reported its earnings results for the fourth quarter of 2025. Revenues were $1.69 billion, compared to $2.00 billion in the same period a year ago. Net
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
Lennar (LEN) continues to battle a stubbornly difficult housing market
Shares of Lennar Corporation (NYSE: LEN) were down 2% on Thursday. The stock has dropped 17% over the past three months. The homebuilder saw its revenues and profits decline in
